Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that a drug candidate with anticancer potential can be activated by one of the body's natural responses to cellular stress. Once activated, the agent can kill prostate cancer cells.
"There is no proven drug right now with these activities," said Ben Shen, vice chair of TSRI's Department of Chemistry and senior author of the new study, "so this points the way toward a new therapeutic opportunity."